Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Felzartamab |
Synonyms | |
Therapy Description |
Felzartamab (MOR202) is a monoclonal antibody that binds CD38, potentially resulting in increased cytoxicity against CD38-expressing tumor cells and tumor cell lysis (PMID: 29654274, PMID: 32171061). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Felzartamab | MOR03087|TJ202|MOR202 | CD38 Antibody 20 | Felzartamab (MOR202) is a monoclonal antibody that binds CD38, potentially resulting in increased cytoxicity against CD38-expressing tumor cells and tumor cell lysis (PMID: 29654274, PMID: 32171061). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|